Julia Garcia-Diaz, MD
- Sr Physician, Southshore Region
- 1514 Jefferson Hwy, New Orleans, LA, 70121
For additional information or to make an appointment, click here.
Overview
Overview
- Dr. Garcia-Diaz is the director of clinical infectious diseases research and medical subspecialties at Ochsner. Dr. Garcia-Diaz earned her medical degree from Louisiana State University and completed her internship, residency and infectious diseases fellowship at Ochsner Medical Foundation. She is board certified in infectious diseases and has been on staff at Ochsner since 1998. Dr. Garcia-Diaz is an associate professor at University of Queensland - Ochsner Clinical School, and a clinical associate professor of Medicine at Tulane. She also oversees the research of medical students in her role as director of medical student researcher. Dr. Garcia-Diaz is a prolific researcher who is active internationally in the field of infectious diseases; she is a certified principal investigator (CPI) and directs infectious diseases clinical research. She is a fellow of the Infectious Diseases Society of America, American College of Physicians and the Association of Clinical Research Professionals. Her professional interests include infections following organ transplantation and other immunocompromised hosts, as well as fungal infections.
Publications
Selected publications
-
2023Whole-genome sequencing of carbapenem-resistant Enterobacterales isolates in southeast Louisiana reveals persistent genetic clusters spanning multiple locations. Journal of Infection and Public Health. 16:1911-1917.
-
2022Clinical Impact of Ceftriaxone Resistance in Escherichia coli Bloodstream Infections: A Multicenter Prospective Cohort Study. OPEN FORUM INFECTIOUS DISEASES. 9.
-
2020A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative People in the United States. Clinical Infectious Diseases. 70:252-261.
-
2019QT prolongation in HIV-positive patients: Review article. Indian Heart Journal. 71:434-439.
-
2019The Outcomes after an Infection in Older Liver Transplant Recipients is Comparable to Younger Adults.. American Journal of Transplantation. 19:418-418.
-
2018
-
2017Draft Genome Sequence of Bacillus cereus LA2007, a Human-Pathogenic Isolate Harboring Anthrax-Like Plasmids. Microbiology Resource Announcements. 5.
-
2016STRIIVING: switching to abacavir/dolutegravir/lamivudine fixed dose combination (ABC/DTG/3TC FDC) from a PI, INI or NNRTI based regimen maintains HIV suppression at week 48. Journal of the International AIDS Society. 19.
-
2016Susceptibility Patterns of Pre-Transplant Pseudomonas and Post-Lung Transplant Outcomes in Patients with Cystic Fibrosis.. American Journal of Transplantation. 16:593-593.
-
2016Vaccination Compliance in Listed Kidney Transplant Candidates: A Retrospective Chart Review.. American Journal of Transplantation. 16:731-731.
-
2015Nocardia-Induced Granulocyte Macrophage Colony-Stimulating Factor Is Neutralized by Autoantibodies in Disseminated/Extrapulmonary Nocardiosis. Clinical Infectious Diseases. 60:1017-1025.
-
2014Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment. Transplant Infectious Disease. 16:270-278.
-
2013Histoplasmosis After Solid Organ Transplant. Clinical Infectious Diseases. 57:1542-1549.
-
2012Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial. American Journal of Transplantation. 12:3021-3030.
-
2010Cutaneous cryptococcosis in solid organ transplant recipients. Medical Mycology. 48:785-791.
-
2010Geographic differences in disease expression of cryptococcosis in solid organ transplant recipients in the United States. Annals of Transplantation. 15:77-83.
-
2010
-
2010Unrecognized Pretransplant and Donor-Derived Cryptococcal Disease in Organ Transplant Recipients. Clinical Infectious Diseases. 51:1062-1069.
-
2009Lipid Formulations of Amphotericin B Significantly Improve Outcome in Solid Organ Transplant Recipients with Central Nervous System Cryptococcosis. Clinical Infectious Diseases. 49:1721-1728.
-
2008
-
2008Pulmonary cryptococcosis in solid organ transplant recipients: Clinical relevance of serum cryptococcal antigen. Clinical Infectious Diseases. 46:E12-E18.